Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment.

Goki SudaAtsushi NagasakaYoshiya YamamotoKen FuruyaKenichi KumagaiMineo KudoKatsumi TerashitaTomoe KobayashiIzumi TsunematsuJunichi YoshidaTakashi MeguroMegumi KimuraJun ItoMachiko UmemuraTakaaki IzumiSeiji TsunematsuFumiyuki SatoYoko TsukudaMasato NakaiTakuya ShoMitsuteru NatsuizakaKenichi MorikawaKoji OgawaNaoya Sakamotonull null

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2017)

Daclatasvir and asunaprevir combination therapy for patients with renal dysfunction was highly effective and safe.

Keyphrases

hepatitis c virus
human immunodeficiency virus
oxidative stress
hiv infected